Innate Pharma S.A. (IPHA) News
Follow Innate Pharma S.A. (IPHA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Sobi and Innate partnership becomes effective after closing conditions
Sobi and Innate Pharma said their previously announced strategic partnership is now effective following completion of closing conditions.
MNA | Sep 17, 2026, 03:30 AM UTC
L
IPHA Price Target Raised
IPHA price target raised to $9 from $8 at BTIG
EQUITY | Aug 12, 2026, 09:45 AM UTC